Found: 18
Select item for more details and to access through your institution.
Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 3, p. 217, doi. 10.1159/000509864
- By:
- Publication type:
- Article
Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
- Published in:
- Neuroendocrinology, 2018, v. 106, n. 2, p. 139, doi. 10.1159/000474941
- By:
- Publication type:
- Article
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01018-w
- By:
- Publication type:
- Article
Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0012038
- By:
- Publication type:
- Article
Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 936, doi. 10.3390/cancers15030936
- By:
- Publication type:
- Article
Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4463, doi. 10.3390/cancers13174463
- By:
- Publication type:
- Article
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00549-2
- By:
- Publication type:
- Article
Loss of UDP-N-acetylglucosamine 2-epimerase/ N-acetylmannosamine kinase (GNE) induces apoptotic processes in pancreatic carcinoma cells.
- Published in:
- FASEB Journal, 2012, v. 26, n. 2, p. 938, doi. 10.1096/fj.11-186700
- By:
- Publication type:
- Article
Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer.
- Published in:
- FASEB Journal, 2011, v. 25, n. 10, p. 3325, doi. 10.1096/fj.11-182287
- By:
- Publication type:
- Article
Tumour suppressor p16<sup>INK4a</sup> - anoikis-favouring decrease in N/ O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model.
- Published in:
- FEBS Journal, 2012, v. 279, n. 21, p. 4062, doi. 10.1111/febs.12001
- By:
- Publication type:
- Article
Tumor suppressor p16<sup>INK4a</sup>: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model.
- Published in:
- FEBS Journal, 2010, v. 277, n. 17, p. 3552, doi. 10.1111/j.1742-4658.2010.07764.x
- By:
- Publication type:
- Article
Nonsteroidal anti-inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G<sub>1</sub> cell-cycle arrest.
- Published in:
- International Journal of Cancer, 2003, v. 107, n. 5, p. 844, doi. 10.1002/ijc.11446
- By:
- Publication type:
- Article
Stimulation of both CCK-A and CCK-B Receptors Activates MAP Kinases in AR42J and Receptor-Transfected CHO Cells.
- Published in:
- Digestion, 1997, v. 58, n. 4, p. 361, doi. 10.1159/000201466
- By:
- Publication type:
- Article
Non‐invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: The DACHS study.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 1, p. 221, doi. 10.1002/ijc.32076
- By:
- Publication type:
- Article
Interferon-α: Regulatory Effects on Cell Cycle and Angiogenesis.
- Published in:
- Neuroendocrinology, 2004, v. 80, p. 85, doi. 10.1159/000080748
- By:
- Publication type:
- Article
Tumor suppressor p16<sup>INK4a</sup> controls oncogenic K-Ras function in human pancreatic cancer cells.
- Published in:
- Cancer Science, 2012, v. 103, n. 2, p. 169, doi. 10.1111/j.1349-7006.2011.02140.x
- By:
- Publication type:
- Article
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182852
- By:
- Publication type:
- Article